Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.49 |
| ▸ | RELA | Q04206 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aceroside I SCHEMBL13698044 | 1.00 | NFKB1 (0.49) | NFKB1NFKB2RELAACHEATM | |
| Aceroside I SCHEMBL15996716 | 1.00 | NFKB1 (0.49) | NFKB1NFKB2RELAACHEATM | |
| Aceroside I SCHEMBL15996710 | 1.00 | NFKB1 (0.49) | NFKB1NFKB2RELAACHEATM | |
| Aceroside B1 SCHEMBL15996711 | 1.00 | NFKB1 (0.49) | NFKB1NFKB2RELAACHEATM | |
| Aceroside B1 SCHEMBL13698046 | 1.00 | NFKB1 (0.49) | NFKB1NFKB2RELAACHEATM | |
| SCHEMBL13698112 | 0.87 | NFKB1 (0.55) | NFKB1NFKB2RELAACHE | |
| SCHEMBL10048264 | 0.87 | NFKB1 (0.55) | NFKB1NFKB2RELAACHE | |
| SCHEMBL13698111 | 0.87 | NFKB1 (0.55) | NFKB1NFKB2RELAACHE | |
| SCHEMBL15996705 | 0.86 | NFKB1 (0.40) | NFKB1NFKB2RELAACHELMNA | |
| SCHEMBL13698048 | 0.86 | NFKB1 (0.40) | NFKB1NFKB2RELAACHELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822705-B2 | Pharmaceutical composition for preventing and/or treating bone disease, functional food or health food and pharmaceutical preparation comprising thereof as active ingredient | Akihisa, Toshihiro (JP) | 2014-09-02 | — | — | US | disclosed |
| US-20090227527-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING BONE DISEASE, FUNCTIONAL FOOD OR HEALTH FOOD AND PHARMACEUTICAL PREPARATION COMPRISING THEREOF AS ACTIVE INGREDIENT | Akihisa, Toshihiro (JP) | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227527-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING BONE DISEASE, FUNCTIONAL FOOD OR HEALTH FOOD AND PHARMACEUTICAL PREPARATION COMPRISING THEREOF AS ACTIVE INGREDIENT | HRH1, HRH2, HRH3 | NFKB1 388/4885NFKB2 1238/4885RELA 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.